Vasorelaxant effect of 3,5,4′-trihydroxy-trans-stilbene (resveratrol) and its underlying mechanism
- 10 January 2020
- journal article
- research article
- Published by Springer Nature in Inflammopharmacology
- Vol. 28 (4) , 869-875
Abstract
Resveratrol is found in numerous plant-based foods and beverages and is known to have an impact on the cardiovascular system. The aim of this study was to investigate the vasorelaxant effect of resveratrol and its underlying mechanisms by employing an aortic ring assay model. Resveratrol caused relaxation of aortic rings that had been precontracted with phenylephrine in the presence of endothelium or with potassium chloride in endothelium-intact aortic rings. The vasorelaxant effect was decreased in the absence of an endothelium. The mechanisms underlying the vasorelaxant effect of resveratrol were determined through the addition of antagonists. In the presence of the endothelium, indomethacin (a nonselective cyclooxygenase inhibitor), methylene blue (cyclic guanosine monophosphate lowering agent), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, selective soluble guanylate cyclase inhibitor), Nω-nitro-l-arginine methyl ester (L-NAME, nitric oxide synthase inhibitor), tetraethylammonium (TEA, nonselective calcium activator potassium channel blocker), 4-aminopyridine (4-AP, voltage-dependent K+ channel blocker), barium chloride (BaCl2, inwardly rectifying K+ channel blocker), glibenclamide (non-specific ATP-sensitive K+ channel blocker) and propranolol (β-adrenergic receptor blocker) led to a significant reduction in the vasorelaxation effect induced by resveratrol. Resveratrol was also found to reduce Ca2+ release from the sarcoplasmic reticulum and block calcium channels. In conclusion, resveratrol targets multiple signalling pathways for exerting its vasorelaxant effects in the rat aortic ring model in both the presence and absence of endothelium.Keywords
This publication has 26 references indexed in Scilit:
- Chronic estradiol-17β exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrolAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Effects of resveratrol and other wine polyphenols on vascular function: an updateThe Journal of Nutritional Biochemistry, 2011
- Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive ratsJournal of Pharmacy and Pharmacology, 2010
- Pharmacology of Store-operated Calcium ChannelsMolecular Interventions, 2010
- Prostaglandins in Action2010
- Obesity and cardiovascular dysfunction: A role for resveratrol?Obesity Research & Clinical Practice, 2009
- Female Rats Fed a High-Fat Diet Were Associated with Vascular Dysfunction and Cardiac Fibrosis in the Absence of Overt Obesity and Hyperlipidemia: Therapeutic Potential of ResveratrolThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endotheliumVascular Pharmacology, 2006
- Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary arteryInternational Journal of Cardiology, 2005
- Activation of two types of Ca2+‐permeable nonselective cation channel by endothelin‐1 in A7r5 cellsBritish Journal of Pharmacology, 1998